About BioCopy
BioCopy is a company based in Basel (Switzerland) founded in 2018 by Niko Bausch and Gunter Roth. BioCopy offers products and services including Drug Discovery Platform, Antibody Engineering, and Precision Screening. BioCopy operates in a competitive market with competitors including BeiGene, Moderna, Incyte, ALX Oncology and MorphoSys, among others.
- Headquarter Basel, Switzerland
- Founders Niko Bausch, Gunter Roth
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biocopy Ag
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$58.01 K (USD), Grant
Sep 30, 2018
-
Investors
European Union
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BioCopy
BioCopy offers a comprehensive portfolio of products and services, including Drug Discovery Platform, Antibody Engineering, and Precision Screening.
AI-based system for matching biotherapeutics to cancer cells.
Automated platform for developing next-generation biotherapeutics.
Tool for speeding up risk assessment in drug discovery.
Funding Insights of BioCopy
Investors in BioCopy
BioCopy has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for BioCopy
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioCopy
Investment portfolio details for BioCopy
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BioCopy
Detailed financials for BioCopy
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biocopy Comparisons
Peer comparison for BioCopy
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BioCopy
BioCopy operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BeiGene, Moderna, Incyte, ALX Oncology and MorphoSys, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Small molecules are developed for cancer and skin disease treatments.
|
|
| Locked | Locked | Locked |
ALX Oncology is focused on advancing cancer treatment therapies.
|
|
| Locked | Locked | Locked |
Therapeutic antibodies for cancer and other diseases are developed.
|
|
| Locked | Locked | Locked |
mRNA therapeutics platform is provided for multi-functional treatments.
|
Detailed competitors of BioCopy
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biocopy
Complete news archive for BioCopy
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioCopy
BioCopy was founded in 2018.
BioCopy is headquartered in Basel, Switzerland. It is registered at Basel, Basel-stadt, Switzerland.
Gunter Roth is the current CEO of BioCopy. They have also founded this company.
BioCopy was founded in 2018 in Basel, Switzerland, within the biotechnology sector. Immunotherapies targeting tumors and autoimmune diseases are developed through drug discovery processes. State-of-the-art microarray technology is employed to expedite immunoprofiling and the screening of T-cell receptors against various antigen-HLA complexes. Operations focus on immuno-oncological therapeutics to address unmet needs in oncology and autoimmunity.
BioCopy's top competitors include Moderna, BeiGene and Strand Therapeutics.
BioCopy offers Drug Discovery Platform, Antibody Engineering, and Precision Screening.
BioCopy has 2 investors. Key investors include European Union, and EIC Fund.